2Nickoloff BJ. Cracking the cytokine code in psoria- sis[J].Nat Med, 2007.13(3):242-244.
3Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and the- rapy of psoriasis[J].Nature,2007,445 (7130):866-873.
4Liu H,Liu ZH, Chen ZH,et al. Triptolide:a potent inhi- bitor of NF-κB in T-lymphocytes[J].hcta Pharmacol Sinica,2000,21(9):782-786.
5Tak PP,Firestein GS. NF-xB:A key role in inflamma- tory diseases[J].J clin Invest,2001,107(1):7-11.
6Lee Jang IK,Pharm D, Gibert J,et al. Nuclear factor kappa B:important transcription factor and thera- pentic target[J].J Clin'Pharmacol,1998,38(11):981- 993.
7Christman JW,Lan Caster LH,Black Well TS,et al. Nu- clear factorxB:a piovtal role in the systemic infl- ammory response syndrome and new target for therapy [J].Intensive Care Med, 1998,24:1131-1138.
8D'Acquisto F,May MJ,Ghosh S. Inhibition of nuclear factor kappa B (NF-B):an emerging theme in anti- inflammatory therapies[J].Mol Interv,2002,2(1):22- 35.
